Genemedi produces core diagnostic ingredients for test of Cardiovascular disease (acute?myocardial infarction) and related syndrome. GeneMedi offers paired diagnostics grade creatine kinase myocardial band (CKMB) antibodies (monoclonal antibody, mab) and antigens for Cardiovascular disease (acute?myocardial infarction) rapid test kit of creatine kinase myocardial band (CKMB) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Cardiovascular disease (acute?myocardial infarction ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.is a?cardiac marker?used to assist diagnoses of an acute?myocardial infarction. It measures the blood level of CK-MB (creatine kinase myocardial band), the bound combination of two variants (isoenzymes?CKM?and?CKB) of the enzyme?phosphocreatine kinase.recently, there have been improvements to the test that involve measuring the ratio of the CK-MB1 and CK-MB2 isoformsThe newer test detects different isoforms of the B subunit specific to the myocardium whereas the older test detected the presence of cardiac-related isoenzyme dimers. Many cases of CK-MB levels exceeding the blood level of total CK have been reported, especially in newborns with cardiac malformations, especially ventricular septal defects. This reversal of ratios is in favor of pulmonary emboli or vasculitis. An autoimmune reaction creating a complex molecule of CK and IgG should be taken into consideration.